Literature DB >> 14747112

Cardiac complications during waiting for elective coronary artery bypass graft surgery: incidence, temporal distribution and predictive factors.

Fernando Henpin Yue Cesena1, Desiderio Favarato, Luiz Antônio Machado César, Sérgio Almeida de Oliveira, Protásio Lemos da Luz.   

Abstract

OBJECTIVES: Since waiting lists for coronary artery bypass graft surgery are common and carry a risk of severe events, the purposes of this study were: (1) to analyse the incidence and temporal distribution of cardiac complications during waiting for elective coronary artery bypass grafting; (2) to identify predictive factors of such complications.
METHODS: Data were collected from 574 patients referred to surgery from 1 January 1998 to 12 July 2001. Two types of complications were defined: (1) a composite end-point, which included cardiac death, myocardial infarction, unstable angina or hospital admission due to cardiac cause; (2) sudden or any cardiac death. Previous cardiac events, risk factors, clinical features, laboratory exams, non-invasive tests for myocardial ischemia, left ventricular function and coronary anatomy were analysed. Kaplan-Meier method, multivariate Cox regression and Student's t-test were used for statistical analyses.
RESULTS: Median time to surgery was 126 days (5-1022). Among 516 patients consecutively referred to the surgery from 1 January 1998 to 31 December 2000, sudden or cardiac death occurred in 2.5% and the composite end-point in 22.9%. Most complications (72.1%) were observed within 120 days. The main factors predictive of sudden or cardiac death were severe left ventricular dysfunction and heart failure (univariate analysis). Independent predictive factors of the composite end-point were angina, heart failure functional classes and high triglyceride levels.
CONCLUSIONS: During long delay for coronary artery bypass surgery, cardiac events are frequent and tend to occur early. Severe left ventricular dysfunction, advanced angina, heart failure functional classes and high triglyceride level must be considered when selection is necessary, in order to diminish morbidity and mortality during the waiting period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747112     DOI: 10.1016/j.ejcts.2003.11.004

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery.

Authors:  Michelle M Graham; Merril L Knudtson; Blair J O'Neill; David B Ross
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

2.  Impact of COVID-19 on Cardiothoracic Surgery: Experience of Alexandria (Egypt) Main University Hospital.

Authors:  Hanan M Hemead; Mohamed H Elsayed; Wael Hassanein
Journal:  Braz J Cardiovasc Surg       Date:  2022-05-23

3.  Coronary surgery for acute coronary syndrome: which determinants of outcome remain?

Authors:  K Alexiou; U Kappert; A Staroske; D Joskowiak; M Wilbring; K Matschke; S M Tugtekin
Journal:  Clin Res Cardiol       Date:  2008-03-31       Impact factor: 5.460

4.  Derivation and validation of a clinical risk score to predict death among patients awaiting cardiac surgery in Ontario, Canada: a population-based study.

Authors:  Louise Y Sun; Harindra C Wijeysundera; Douglas S Lee; Sean van Diepen; Marc Ruel; Anan Bader Eddeen; Thierry G Mesana
Journal:  CMAJ Open       Date:  2022-03-08

5.  Derivation and validation of a clinical model to predict death or cardiac hospitalizations while on the cardiac surgery waitlist.

Authors:  Louise Y Sun; Anan Bader Eddeen; Harindra C Wijeysundera; Mamas A Mamas; Derrick Y Tam; Thierry G Mesana
Journal:  CMAJ       Date:  2021-08-30       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.